pubmed-article:1268845 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1268845 | lifeskim:mentions | umls-concept:C0302592 | lld:lifeskim |
pubmed-article:1268845 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:1268845 | lifeskim:mentions | umls-concept:C1556094 | lld:lifeskim |
pubmed-article:1268845 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:1268845 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:1268845 | lifeskim:mentions | umls-concept:C0041361 | lld:lifeskim |
pubmed-article:1268845 | lifeskim:mentions | umls-concept:C0376249 | lld:lifeskim |
pubmed-article:1268845 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
pubmed-article:1268845 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:1268845 | pubmed:dateCreated | 1976-8-2 | lld:pubmed |
pubmed-article:1268845 | pubmed:abstractText | Microquantitative complement fixation was used to detect antibody to AG-4, a tumor-associated herpesvirus type 2-induced antigen, in sera from Japanese patients with cervical neoplasia. The prevalence of antibody to AG-4 in cervical cancer patients is 47% as compared to 7% in control women. That AG-4 antibody is less prevalent in Japanese than in American cancer patients reflects the frequency of genital herpesvirus type 2 infections in Japan. These findings confirm the association of AG-4 with cervical cancer in a proportion of Japanese patients with neoplastic disease; they implicate factors other than herpesvirus type 2 in another proportion of cervical cancer patients. The possibility that herpesvirus type 1 is one of these factors is considered. | lld:pubmed |
pubmed-article:1268845 | pubmed:language | eng | lld:pubmed |
pubmed-article:1268845 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1268845 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1268845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1268845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1268845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1268845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1268845 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1268845 | pubmed:month | Jun | lld:pubmed |
pubmed-article:1268845 | pubmed:issn | 0008-5472 | lld:pubmed |
pubmed-article:1268845 | pubmed:author | pubmed-author:AurelianLL | lld:pubmed |
pubmed-article:1268845 | pubmed:author | pubmed-author:KawanaTT | lld:pubmed |
pubmed-article:1268845 | pubmed:author | pubmed-author:SmithM FMF | lld:pubmed |
pubmed-article:1268845 | pubmed:author | pubmed-author:CornishJ DJD | lld:pubmed |
pubmed-article:1268845 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1268845 | pubmed:volume | 36 | lld:pubmed |
pubmed-article:1268845 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1268845 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1268845 | pubmed:pagination | 1910-4 | lld:pubmed |
pubmed-article:1268845 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:meshHeading | pubmed-meshheading:1268845-... | lld:pubmed |
pubmed-article:1268845 | pubmed:year | 1976 | lld:pubmed |
pubmed-article:1268845 | pubmed:articleTitle | Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls. | lld:pubmed |
pubmed-article:1268845 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1268845 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1268845 | lld:pubmed |